Welcome to International Network for Natural Sciences | INNSpub

Effects of height and organs on flavonoids of Crataegus microphylla C. Koch in Iran

Research Paper | July 1, 2012

| Download 5

Ali Akbar Tajali, Mehrdad Khazaeipool

Key Words:

Int. J. Biosci.2( 7), 54-58, July 2012


IJB 2012 [Generate Certificate]


This study was conducted to evaluate the effect of height and organs on the amount of two flavonoids in Rutin and Quercetin in three height lines of 100, 1000 and 2000 m in the heights of the north of Iran. To study the effect of height and organ on the amount of two flavonoids of Rutin and Quercetin, the simple nested experimental design was used and in each height two organs (flower and leaf) was studied to measure Rutin and Quercetin and all the plant organs were used to measure the total flavonoids. The average comparisons determined that 100 m height has the highest amount of Rutin and Quercetin also a significant difference was observed in 1% level between the amount of Rutin and Quercetin in flowers and leaves at different heights. The amount of Rutin in all three heights was in the leaf more than in the flower, but for Quercetin the reverse was true so that the amount of this material in all three heights were in the flower more than in the leaf. The effect of height on the amount of total flavonoids was significant in 1% level as its highest amount was observed at 1000 m height.


Copyright © 2012
By Authors and International Network for
Natural Sciences (INNSPUB)
This article is published under the terms of the Creative
Commons Attribution Liscense 4.0

Effects of height and organs on flavonoids of Crataegus microphylla C. Koch in Iran

Amin GR. 2005. Popular Medicinal Plants of Iran. Tehran University of Medical Sciences. p. 300

Barceloux DG. 2012. Medical Toxicology of Natural Substances: Foods, Fungi, Medicinal Herbs, Plants, and Venomous Animals. John Wiley & Sons. P. 1170.

Cushnie TP, Lamb AJ. 2005. Antimicrobial activity of flavonoids. International Journal of Antimicrobial Agents 26 (5), 343–356.

Cushnie TP, Lamb AJ. 2011. Recent advances in understanding the antibacterial properties of flavonoids”. International Journal of Antimicrobial Agents 38 (2), 99–107.

Davise FS, Albrigo LG. 1994. Citrus . CAB International press, wallington , UK

De Sousa RR, Queiroz KC, Souza AC, Gurgueira SA, Augusto AC, Miranda MA, Peppelenbosch MP, Ferreira CV, Aoyama H. 2007. Phosphoprotein levels, MAPK activities and NFkappaB expression are affected by fisetin. Journal Enzyme Inhibition Medicinal Chemistry 22 (4), 439–444.

Hemmati K, Bashiri Sadr Z, Barzali M, Kalati H. 2005. Effect of climate and different organs on flavonoids content in Hawthorn shrub(Crataegus monogyna). Journal of Agriculture Sciences and Natural Resources 14(5), 151-160

Kao ES, Wang CJ, Lin WL, Chu CY, Tseng TH. 2007. Effects of polyphenols derived from fruit of Crataegus pinnatifida on cell transformation, dermal edema and skin tumor formation by phorbol ester application. Food and Chemical Toxicology, 45(10), 1795–1804.

National Meteorological Library and Archive(Met Office). 2007. U.K. Fact Sheet No. 9 Peter J.I., Richard C. 1993. Plant biochemistry and molecular biology. John wiley publisher, NewYork, p. 191-195.

Phipps  JB,  O’Kennon  RJ,  Lance  RW.  2003. Hawthorns and medlars. Royal Horticultural Society, Cambridge, U.K.

Schuier M, Sies H, Illek B, Fischer H. 2005. Cocoa-related flavonoids inhibit CFTR-mediated chloride transport across T84 human colon epithelia. Journal of Nutrition 135(10), 2320–5.

Rio JA, Fuster MD, Sabater F, Porras I, Lindon AG, Ortuno A. 1995. Effect of benzylaminopurine on the flavanones hesperidin, hesperetin 7-0 glucoside, and pruin in Tangelo Nova fruits. Journal of Agricultural Food Chemistrym 43(8), 2030-2034.

Seymour  GB,  Taylor  JE,  Tuker  GA.  1993. Biochemistry  of  fruit  ripening.  Chapman  and  hall press. p. 453.

Spencer JP. 2008. “Flavonoids: modulators of brain function?”. British Journal of Nutrition 99, 60–77.

Yamamoto  Y,  Gaynor  R.  2001.  Therapeutic potential of inhibition of the NF-κB pathway in the treatment  of  inflammation  and  cancer.  Journal  of Clinical Investigation. 107(2), 135.